All other professional, scientific and technical activities n.e.c.
PHARMALEX NORWAY AS
Revenue 2025
NOK 20.6m
Operating profit
NOK −3.8m
Equity
NOK −329,000
Incorporated
2004
Employees
13
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 20.6m | |
| Total operating costs | 24.4m | |
| Operating profit (EBIT) | −3.8m | |
| Net financial items | −211k | |
| Profit for the year | −4.0m |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 9.9m | |
| of which current assets | 9.8m | |
| Equity | −329k | |
| Total liabilities | 10.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.